UBS ETF Please confirm that you are resident in Finland to proceed.

ETF Comparison

UBS ETF (LU) Bloomberg Barclays USD Emerging Markets Sovereign UCITS ETF (hedged to CHF) A-acc

ISIN LU1324516720
Replication Physical
Asset class Fixed Income
Fee 0.47%

Select a fund for comparison

Name of fund

UBS ETF – Bloomberg Barclays USD Emerging Markets Sovereign UCITS ETF

Share class

UBS ETF – Bloomberg Barclays USD Emerging Markets Sovereign UCITS ETF (hedged to CHF) A-acc

ISIN

LU1324516720

Asset Class

Fixed Income

Fund domicile

LU

Fund type

open-end

Benchmark

Bloomberg Barclays Emerging Markets USD Sovereign & Agency 3% Country Capped Index hedged to CHF

UCITS V

yes

Launch date

31.03.2016

Currency of share class

CHF

Accounting year end

31 December

Replication methodology

physical stratified sampling

  • The fund generally invests in Emerging Markets Bonds which are contained in the Bloomberg Barclays Emerging Markets USD Sovereign & Agency 3% Country Capped Index hedged to CHF. Weightings of the bond correspond to their weightings in the index.
  • The investment objective is to replicate the price and return performance of the Bloomberg Barclays Emerging Markets USD Sovereign & Agency 3% Country Capped Index hedged to CHF net of fees. The stock exchange price may differ from the net asset value.
  • The fund is passively managed.

Management fee p.a.

0.47%

Flat fee p.a.

0.47%

Total expense ratio (TER) p.a.1)

0.47%

  • The Bloomberg Barclays Emerging Markets USD Sovereign & Agency 3% Country Capped Index hedged to CHF is a market capitalization weighted index that tracks fixed and floating-rate US dollar-denominated debt issued by sovereign and agency EM issuers. Country weights are capped at 3% of total amount outstanding of all eligible issues. Exchange rate fluctuations between the foreign currency and index currency are reduced by the sale of foreign exchange contracts with a term of one month.

For marketing and information purposes by UBS.

For professional clients. The information and opinions contained in this document have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document. UBS AG and / or other members of the UBS Group may have a position in and may make a purchase and / or sale of any of the securities or other financial instruments mentioned in this document.

UBS funds under Luxembourg and Irish law

Before investing in a product please read the latest prospectus carefully and thoroughly. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS AG. Source for all data and charts (if not indicated otherwise): UBS Asset Management 

This document contains statements that constitute “forward-looking statements”, including, but not limited to, statements relating to our future business development. While these forward-looking statements represent our judgments and future expectations concerning the development of our business, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from our expectations.

Prospectuses, simplified prospectuses or key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available in a language required by the local applicable law free of charge from UBS Asset Management, Regeringsgatan 38, S-11153 Stockholm.

© UBS 2021. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.